Sellbyville, DE -- (SBWIRE) -- 04/26/2019 -- The Esoteric Testing Market to exceed USD 35 billion by 2024; according to a new research report by Global Market Insights. Rising number of people suffering from rare diseases has escalated burden on healthcare systems to develop innovative test solutions, thereby fueling industry growth. Furthermore, sophistication of laboratory equipment leading to growing adoption of ground breaking technologies such as flow cytometry, mass spectrometry and real time-PCR will favor industry growth.

Increasing prevalence of chronic diseases and infectious diseases in developing countries such as China along with rising geriatric population, highly susceptible to suffer from chronic disorders will drive esoteric testing market over the forecast timeframe. Growing awareness about early disease detection along with rising demand for genomics and proteomic will positively impact market growth over the forecast period. However, lack of trained professionals and stringent regulations related with esoteric tests will restrain industry growth in future.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1922

Personalized medicine has of late become clinical reality, a factor that has led to huge investments in proteomics and genomics industry. Increasing sophistication of the laboratory instruments along with growing implementation of advanced technologies like bioinformatics for complex disease treatment have upscaled the demand for esoteric testing market lately. Esoteric testing allows in-depth analysis of molecules that are not routinely performed in a clinical lab, subject to skilled medical technologists' requirement and the expensive cost associated with these tests. Thus, many commercial laboratories outsource these complex tests to reference laboratories that are specialized in esoteric testing. However, with technology being profoundly penetrating the laboratory service space, many of the medium sized labs nowadays are performing these tests in-house. The massive surge in R&D investments is expected to expand esoteric testing industry periphery in the years ahead.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- Myriad Genetics
- Litholink / Laboratory Corporation of America
- Mayo Medical Laboratories
- Miraca Holdings Inc.
- Nordic
- Immunological laboratories BV
- Quest Diagnostics
- Genomic Health
- ARUP Laboratories
- ACM Global Laboratories
- American
- Esoteric Laboratories
- Fulgent Genetics
- OPKO Health, Inc.

Globally, esoteric testing industry is highly regulatory driven, with mandatory roll outs by FDA and CLIA (Clinical Laboratory Improvement Amendments) that these clinical labs are required to comply with. In fact, stringent regulatory framework and uncomplimentary reimbursement scenario hinder the market penetration across some of the domains to some extent. While FDA regulates reagents, test kits, and other instruments that are widely deployed in esoteric laboratories for diagnostic purpose, highly complex testing laboratories require CLIA certification for performing these tests. The requirement of complying with all these regulatory approaches has resulted in an increased burden on small to medium sized laboratories. Amidst this backdrop, business collaboration is emerging as a top-notch strategy in the competitive landscape of esoteric testing market.

The strategic partnership of U.S. based metagenomics firm IDbyDNA with ARUP Laboratories is a testimony to the aforementioned aspect. Reportedly, with this collaboration, the firms aim to develop and commercialize advanced NGS (next generation sequencing) tests that are claimed to be more accurate and comprehensive. The partnership also outlines integration of laboratory medicine with data-driven analytics to exploit the benefits of precision medicine in infectious disease treatment. Market experts claim that similar kinds of collaboration will bring advanced genetic technology into clinical practice more rapidly, subsequently enhancing esoteric testing market outlook. In this regard, it is important to note that market giants have been really optimistic and are betting big on Infectious disease and immunology, which in 2017, procured 28% of the overall esoteric testing industry landscape.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1922

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Esoteric testing industry 3600 synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Test-type trends

2.1.3. Technology trends

2.1.4. Regional trends

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/esoteric-testing-market

Chapter 3. Esoteric Testing Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.2. Industry pitfalls & challenges

3.4. Growth potential analysis

3.4.1. By test-type

3.4.2. By technology

3.5. Types of business models

3.5.1. Mobile lab services

3.5.2. Full service diagnostics

3.5.3. Reference/ Consulting Services